QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

Alzheimer's disease (AD) is a neurodegenerative disease that affects a wide range of populations and is the primary cause of death in various countries. The treatment of AD is still restricted to oral conventional medicines that act only superficially. Fabrication of intranasal solid lipid nano...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Deepshi, Bhatt, Shailendra, Kumar, Manish, Verma, Ravinder, Taneja, Yugam, Kaushal, Nikita, Tiwari, Abhishek, Tiwari, Varsha, Alexiou, Athanasios, Albogami, Sarah, Alotaibi, Saqer S., Mittal, Vineet, Singla, Rajeev K., Kaushik, Deepak, Batiha, Gaber El-Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407039/
https://www.ncbi.nlm.nih.gov/pubmed/36034142
http://dx.doi.org/10.3389/fnagi.2022.960246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407039/
https://www.ncbi.nlm.nih.gov/pubmed/36034142
http://dx.doi.org/10.3389/fnagi.2022.960246

Ejemplares similares